Symbols

QDEL

QuidelOrtho·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

MACD Golden Cross

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About QDEL

Quidelortho Corporation

A global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine

Industry

Healthcare Equipment and Supplies

Established Date

12/17/2021

Listing Date

08/07/1981

Exchange

NASDAQ Stock Exchange

Full-time Employees

6,500

Fiscal Year Ends

12-31

Website

www.quidelortho.com

Security Type

Common stock

Office address

9975 Summers Ridge Road, San Diego, California 92121

Business

Introduction

QuidelOrtho Corporation was incorporated in Delaware on December 17, 2021. The company's global infrastructure and business coverage provides customers in more than 140 countries with high-quality diagnostics, extensive test portfolios and market-leading services. The company operates globally, with manufacturing facilities in the United States, the United Kingdom and China, as well as sales centers, administrative offices and warehouses around the world. The company currently sells products directly to end users through a direct sales team and a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, emergency clinics, universities, retail clinics, pharmacies, health screening centers, other POC institutions, blood banks and donor centers, as well as personal, non-professional, OTC use.

Company Financials

EPS

QDEL has released its 2025 Q4 earnings. EPS was reported at 0.46, versus the expected 0.43, beating expectations. The chart below visualizes how QDEL has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

QDEL has released its 2025 Q4 earnings report, with revenue of 723.60M, reflecting a YoY change of 2.23%, and net profit of -130.70M, showing a YoY change of 26.74%. The Sankey diagram below clearly presents QDEL's revenue sources and cost distribution.